Business
Press Release Aug 19 2024
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 19, 2024, titled "Glenmark Therapeutics Inc., USA launches Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1% (OTC)".
About this update from Glenmark Pharmaceuticals Limited
[{"type":"text","content":" Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 19, 2024, titled \"Glenmark Therapeutics Inc., USA launches Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1% (OTC)\". View Attachment","length":370,"tagName":"div"}]